Side effects associated with homogenous and heterogenous doses of Oxford-AstraZeneca vaccine among adults in Bangladesh: an observational study.
Autor: | Sharif N; Department of Microbiology, Jahangirnagar University, Savar, Dhaka-1342, Savar, Dhaka, 1342, Bangladesh. nadim@juniv.edu., Opu RR; Department of Microbiology, Jahangirnagar University, Savar, Dhaka-1342, Savar, Dhaka, 1342, Bangladesh., Saha T; Department of Microbiology, Jahangirnagar University, Savar, Dhaka-1342, Savar, Dhaka, 1342, Bangladesh., Khan A; Department of Statistics and Data Science, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh., Aljohani A; Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia., Alsuwat MA; Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia., García CO; Universidad Europea del Atlántico, Isabel Torres 21, Santander, 39011, Spain.; Universidad Internacional Iberoamericana, Campeche, 24560, México., Vázquez AA; Universidad Europea del Atlántico, Isabel Torres 21, Santander, 39011, Spain.; Universidad Internacional Iberoamericana, Campeche, 24560, México.; Universidad de La Romana, La Romana, República Dominicana., Alzahrani KJ; Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia., Miramontes-González JP; Facultad de Medicina. Departamento de Medicina, University of Valladolid, Valladolid, Spain., Dey SK; Department of Microbiology, Jahangirnagar University, Savar, Dhaka-1342, Savar, Dhaka, 1342, Bangladesh. shuvradey@yahoo.com. |
---|---|
Jazyk: | angličtina |
Zdroj: | Scientific reports [Sci Rep] 2024 Oct 11; Vol. 14 (1), pp. 23794. Date of Electronic Publication: 2024 Oct 11. |
DOI: | 10.1038/s41598-024-75833-z |
Abstrakt: | Assessment of side effects associated with COVID-19 vaccination is required to monitor safety issues and acceptance of vaccines in the long term. We found a significant knowledge gap in the safety profile of COVID-19 vaccines in Bangladesh. We enrolled 1805 vaccine recipients from May 5, 2021, to April 4, 2023. Kruskal-Wallis test and χ2 test were performed. Multivariable logistic regression was also performed. First, second and third doses were administered among 1805, 1341, and 923 participants, respectively. Oxford-AstraZeneca (2946 doses) was the highest administered followed by Sinopharm BIBP (551 doses), Sinovac (214 doses), Pfizer-BioNTech (198 doses), and Moderna (160 doses), respectively. Pain at the injection site (80-90%, 3200-3600), swelling (85%, 3458), redness (78%, 3168), and heaviness in hand (65%, 2645) were the most common local effects, and fever (85%, 3458), headache (82%, 3336), myalgia (70%, 2848), chills (67%, 2726), muscle pain (60%, 2441) were the most prevalent systemic side effects reported within 48 h of vaccination. Thrombosis was only reported among the Oxford-AstraZeneca recipients (3.5-5.7%). Both local and systemic effects were significantly associated with the Oxford-AstraZeneca (p-value < 0.05), Pfizer-BioNTech (p-value < 0.05), and Moderna (p-value < 0.05) vaccination. Chronic urticaria and psoriasis were reported by 55-60% of the recipients after six months or later. The highest percentage of local and systemic effects after 2nd and 3rd dose were found among recipients of Moderna followed by Pfizer-BioNTech and Oxford-AstraZeneca. Homogenous doses of Oxford-AstraZeneca and heterogenous doses of Moderna and Pfizer-BioNTech were significantly associated with elevated adverse effects. Females, aged above 60 years with preexisting health conditions had higher risks. Vaccination with Pfizer-BioNTech (OR 4.34, 95% CI 3.95-4.58) had the highest odds of severe and long-term effects followed by Moderna (OR 4.15, 95% CI 3.92-4.69) and Oxford-AstraZeneca (OR 3.89, 95% CI 3.45-4.06), respectively. This study will provide an integrated insight into the safety profile of COVID-19 vaccines. (© 2024. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |